WO2021023207A1
|
|
Jak kinase inhibitor and use thereof
|
CN111848626A
|
|
TRK kinase inhibitor and application thereof
|
CN111233891A
|
|
Fused ring pyridone derivative and preparation method and application thereof
|
CN111333685A
|
|
Synthetic method of FXR antagonist SIPI7623 metabolite
|
CN110577501A
|
|
indoleamine 2, 3-dioxygenase modulators, method for the production and use thereof
|
CN110540495A
|
|
synthetic process of camphor oxide
|
CN110538141A
|
|
oxycocamphor injection and preparation method thereof
|
CN110540494A
|
|
Oxycocamphor crystal-form compound and preparation method thereof
|
CN108379257A
|
|
Dimethylaminoethyl ginkgolide B mesylate is preparing the application in preventing or treating asthmatic medicament
|
CN108117561A
|
|
A kind of dimethylaminoethyl ginkgolide B mesylate metabolite and synthesis and purification process
|
CN108117503A
|
|
Pyrroles's sulphonyl class new chemical entities, preparation method and its usage
|
CN108069891A
|
|
A crystal forms, preparation and its application of a kind of methyl methylamine hydrochloride
|
CN107875387A
|
|
A kind of compound medicine containing pyrroles's sulphonyl analog derivative and application thereof
|
CN107879964A
|
|
The base of 1 (5 (2 fluorophenyl) 13 (3 methoxypropoxy) benzene sulfonyl chloride) 1H pyrroles 3) N methyl amines preparation method
|
CN107281280A
|
|
A kind of application of Radix Serratulae Chinensis extract in prevention and/or treatment pulmonary hypertension medicine is prepared
|
CN106905408A
|
|
1- carbonyl tanshinone IIA derivatives and its preparation
|
CN106632246A
|
|
Crystalline form of pyrrole-type gastric acid secretion inhibitor compound salt and preparation thereof
|
WO2016045598A1
|
|
4-substituted pyrrolo[2,3-d]pyrimidine compound and use thereof
|
CN106546689A
|
|
A kind of HPLC analysis methods of amber love song Ge Lieting bulk drugs and its preparation enantiomter
|
CN106316973A
|
|
Angiotensin receptor antagonist as well as NEP inhibitor drug crystal form and preparation thereof
|